Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil E Martin

Showing results (41-50 of 123) with videos related to

Pageof 13
Sort By:
European Urology|November 8, 2017
Reply to Aditya Bagrodia, Solomon Woldu, David F. Penson, Alexander Kutikov, and Samuel D. Kaffenberger's Letter to the Editor re: Sophia C. Kamran, Thomas Seisen, Sarah C. Markt, et al. Contemporary Treatment Patterns and Outcomes for Clinical Stage IS Testicular Cancer. Eur Urol 2018;73:262-70Thomas Seisen, Sophia C Kamran, Sarah C Markt, et al.
Clinical Genitourinary Cancer|September 8, 2020
Development and Validation of a Novel TP53 Mutation Signature That Predicts Risk of Metastasis in Primary Prostate CancerFallon E Chipidza, Mohammed Alshalalfa, Brandon A Mahal, et al.
European Urology|January 24, 2018
Reply to Christian D. Fankhauser, Nico C. Grossmann, Joerg Beyer, and Thomas Hermanns' Letter to the Editor re: Sophia C. Kamran, Thomas Seisen, Sarah C. Markt, et al. Contemporary Treatment Patterns and Outcomes for Clinical Stage IS Testicular Cancer. Eur Urol 2018;73:262-70Sophia C Kamran, Thomas Seisen, Sarah C Markt, et al.
International Journal of Radiation Oncology, Biology, Physics|May 8, 2014
Refusal of curative radiation therapy and surgery among patients with cancerAyal A Aizer, Ming-Hui Chen, Arti Parekh, et al.
Brachytherapy|August 6, 2013
Dosimetric quality and evolution of edema after low-dose-rate brachytherapy for small prostates: implications for the use of newer isotopesKonstantin A Kovtun, Luciant Wolfsberger, Thomas Niedermayr, et al.
Cancer|May 28, 2014
Lack of reduction in racial disparities in cancer-specific mortality over a 20-year periodAyal A Aizer, Tyler J Wilhite, Ming-Hui Chen, et al.
International Journal of Radiation Oncology, Biology, Physics|March 15, 2016
Association Between Treatment at a High-Volume Facility and Improved Survival for Radiation-Treated Men With High-Risk Prostate CancerYu-Wei Chen, Brandon A Mahal, Vinayak Muralidhar, et al.
Advances in Radiation Oncology|July 26, 2017
Characterization of efficacy and toxicity after high-dose pelvic reirradiation with palliative intent for genitourinary second malignant neoplasms or local recurrences after full-dose radiation therapy in the pelvis: A high-volume cancer center experienceSophia C Kamran, Lauren C Harshman, Mandar S Bhagwat, et al.
Practical Radiation Oncology|March 29, 2014
Low rate of clinician-scored gynecomastia induced by 6 months of combined androgen blockade in a randomized trial: Implications for prophylactic breast irradiationAmar U Kishan, Ming-Hui Chen, Marian Loffredo, et al.
The Journal of Molecular Diagnostics : JMD|May 5, 2015
Comparing Platforms for Messenger RNA Expression Profiling of Archival Formalin-Fixed, Paraffin-Embedded TissuesSvitlana Tyekucheva, Neil E Martin, Edward C Stack, et al.
Pageof 13

Showing results (41-50 of 123) with videos related to

Sort By:
Pageof 13
European Urology|November 8, 2017
Reply to Aditya Bagrodia, Solomon Woldu, David F. Penson, Alexander Kutikov, and Samuel D. Kaffenberger's Letter to the Editor re: Sophia C. Kamran, Thomas Seisen, Sarah C. Markt, et al. Contemporary Treatment Patterns and Outcomes for Clinical Stage IS Testicular Cancer. Eur Urol 2018;73:262-70Thomas Seisen, Sophia C Kamran, Sarah C Markt, et al.
Clinical Genitourinary Cancer|September 8, 2020
Development and Validation of a Novel TP53 Mutation Signature That Predicts Risk of Metastasis in Primary Prostate CancerFallon E Chipidza, Mohammed Alshalalfa, Brandon A Mahal, et al.
European Urology|January 24, 2018
Reply to Christian D. Fankhauser, Nico C. Grossmann, Joerg Beyer, and Thomas Hermanns' Letter to the Editor re: Sophia C. Kamran, Thomas Seisen, Sarah C. Markt, et al. Contemporary Treatment Patterns and Outcomes for Clinical Stage IS Testicular Cancer. Eur Urol 2018;73:262-70Sophia C Kamran, Thomas Seisen, Sarah C Markt, et al.
International Journal of Radiation Oncology, Biology, Physics|May 8, 2014
Refusal of curative radiation therapy and surgery among patients with cancerAyal A Aizer, Ming-Hui Chen, Arti Parekh, et al.
Brachytherapy|August 6, 2013
Dosimetric quality and evolution of edema after low-dose-rate brachytherapy for small prostates: implications for the use of newer isotopesKonstantin A Kovtun, Luciant Wolfsberger, Thomas Niedermayr, et al.
Cancer|May 28, 2014
Lack of reduction in racial disparities in cancer-specific mortality over a 20-year periodAyal A Aizer, Tyler J Wilhite, Ming-Hui Chen, et al.
International Journal of Radiation Oncology, Biology, Physics|March 15, 2016
Association Between Treatment at a High-Volume Facility and Improved Survival for Radiation-Treated Men With High-Risk Prostate CancerYu-Wei Chen, Brandon A Mahal, Vinayak Muralidhar, et al.
Advances in Radiation Oncology|July 26, 2017
Characterization of efficacy and toxicity after high-dose pelvic reirradiation with palliative intent for genitourinary second malignant neoplasms or local recurrences after full-dose radiation therapy in the pelvis: A high-volume cancer center experienceSophia C Kamran, Lauren C Harshman, Mandar S Bhagwat, et al.
Practical Radiation Oncology|March 29, 2014
Low rate of clinician-scored gynecomastia induced by 6 months of combined androgen blockade in a randomized trial: Implications for prophylactic breast irradiationAmar U Kishan, Ming-Hui Chen, Marian Loffredo, et al.
The Journal of Molecular Diagnostics : JMD|May 5, 2015
Comparing Platforms for Messenger RNA Expression Profiling of Archival Formalin-Fixed, Paraffin-Embedded TissuesSvitlana Tyekucheva, Neil E Martin, Edward C Stack, et al.
Pageof 13